Expert Presentations - Type 2 Diabetes

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

alexa.stelzer — Tue, 02 Sep 2025 18:36:32 +0000

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

09/12/2025

alexa.stelzer Tue, 09/02/2025 - 18:36

Presented August 8, 2025

Empowering Behavior Change in Metabolic Health: How Stelo by Dexcom Supports a Person-Centered Approach

Segment 3: Evidence of Impact: Validating the Behavioral Approach

Event: ADCES25 - Sponsored by Association of Diabetes Care & Education Specialists (ADCES)

Location: Phoenix, AZ

Date: August 8, 2025

Speaker: Maggie Crawford, PhD, MPH, Sr Manager Data Science at Dexcom

Session Overview:

In this 14-minute video, Dr. Maggie Crawford presents the third of three segments in the "Empowering Behavior Change in Metabolic Health" session, introducing Dexcom's Quantitative Research Team and the behavioral science evidence supporting Stelo.

Video Timestamps:

[01:34] Dexcom's Quantitative Research Team
[02:11] Behavioral Science Evidence
[03:39] Real-World Dexcom CGM Use in T2D NIT Evidence
[07:12] Early Experiences with Stelo Evidence
[12:48] Takeaways

Watch the first two segments from this session:

Segment 1: Why Behavioral Science for HCPs?
Segment 2: Understanding Behavior Maps: Turning Data Into Action

^{This is a recording of a live presentation. The information you see or hear at this event provides details about medical products which are not available in all countries, may have different indications, and/or have not received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing shown or stated herein should be construed as a solicitation, advertisement, or promotion of any product, or of an indication of any specific use for any product, which is not authorized by the laws and regulations of the country where you reside.}

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10691

Expert Presentations

Expert Presentations - Type 2 Diabetes

OTC Glucose Sensing

Yes

Related Resources

ADCES 2025 - Why Behavioral Science for HCPs?

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

Premium Content

Off

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

alexa.stelzer — Tue, 02 Sep 2025 17:29:18 +0000

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

09/12/2025

alexa.stelzer Tue, 09/02/2025 - 17:29

Presented August 8, 2025

Empowering Behavior Change in Metabolic Health: How Stelo by Dexcom Supports a Person-Centered Approach

Segment 2: Understanding Behavior Maps: Turning Data Into Action

Event: ADCES25 - Sponsored by Association of Diabetes Care & Education Specialists (ADCES)

Location: Phoenix, AZ

Date: August 8, 2025

Speaker: Siddharth Menon, MS, Data Scientist, Dexcom

Session Overview:

In this 12-minute video, Siddharth Menon presents the second of three segments in the "Empowering Behavior Change in Metabolic Health" session, explaining how behavior maps are used to develop and design Stelo features.

Video Timestamps:

[00:53] Why Behavioral Mapping Matters
[02:20] Definition of Key Terms
[03:45] What is a Behavior Map?
[05:38] Case Study: Spike Detection
[10:59] Support Between Appointments

Watch additional segments from this session:

Segment 1: Why Behavioral Science for HCPs?
Segment 3: Evidence of Impact: Validating the Behavioral Approach

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10689

Expert Presentations

Expert Presentations - Type 2 Diabetes

OTC Glucose Sensing

Yes

Related Resources

ADCES 2025 - Why Behavioral Science for HCPs?

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

Premium Content

Off

ADCES 2025 - Why Behavioral Science for HCPs?

alexa.stelzer — Tue, 02 Sep 2025 16:52:10 +0000

ADCES 2025 - Why Behavioral Science for HCPs?

09/12/2025

alexa.stelzer Tue, 09/02/2025 - 16:52

Presented August 8, 2025

Empowering Behavior Change in Metabolic Health: How Stelo by Dexcom Supports a Person-Centered Approach

Segment 1: Why Behavioral Science for HCPs?

Event: ADCES25 - Sponsored by Association of Diabetes Care & Education Specialists (ADCES)

Location: Phoenix, AZ

Date: August 8, 2025

Speaker: Harsimran (Sim) Singh, PhD, MA, Behavioral Informatics Lead, Dexcom

Session Overview:

In this 15-minute video, Sim Singh presents the first of three segments in the "Empowering Behavior Change in Metabolic Health" session, exploring how Dexcom places behavior change at the center of innovation in metabolic health with Stelo.

Video Timestamps:

[02:58] Key takeaway: Small nudges change clinic visits
[03:35] Behavioral Science in Diabetes Care
[08:23] Dexcom's Commitment to Behavioral Science
[12:32] Why Stelo?

This segment laid the groundwork for two additional presentations:

Segment 2: Understanding Behavior Maps: Turning Data Into Action
Segment 3: Evidence of Impact: Validating the Behavioral Approach

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10688

Expert Presentations

Expert Presentations - Type 2 Diabetes

OTC Glucose Sensing

Yes

Related Resources

ADCES 2025 - Understanding Behavior Maps: Turning Data Into Action

ADCES 2025 - Evidence of Impact: Validating the Behavioral Approach

Premium Content

Off

ADA 2025 - Living Your Best Life with Lance Bass

alexa.stelzer — Mon, 11 Aug 2025 23:20:09 +0000

ADA 2025 - Living Your Best Life with Lance Bass

08/21/2025

alexa.stelzer Mon, 08/11/2025 - 23:20

Presented June 21, 2025

Living Your Best Life: Say "Bye" to Fingersticks*, Guesswork, and Uncertainty

Event: American Diabetes Association (ADA) 85th Scientific Sessions

Location: Chicago, IL

Date: June 21, 2025

Speakers:

Lance Bass: Grammy nominated singer, dancer, actor, and producer; Dexcom Warrior
Anita Swamy, MD: Assistant Professor, Northwestern University Feinberg School of Medicine; Department of Pediatrics, Division of Pediatric Endocrinology; Associate Clinician, Ann and Robert H. Lurie Children's Hospital of Chicago; Medical Director, Chicago Children's Diabetes Center

Session Overview:

In this 26-minute presentation from the 85th Scientific Sessions, Lance Bass talks with Dr. Anita Swamy during the final segment of the "Expanding the Dexcom Portfolio" session. Lance shares his journey from being misdiagnosed with type 2 diabetes to discovering he has latent autoimmune diabetes in adults (LADA), and how this diagnosis has led him take better care of his health and inspire others as a Dexcom Warrior. This session is part of a three-part presentation that also included: Team Case, Education, and Early CGM Use in Type 2 Diabetes and Innovations in Dexcom Technology.

Video Timestamps:

[00:01] Dexcom Warrior Program
[00:23] Lance Bass Introduction
[02:40] Lance's Diagnosis Story
[06:04] Favorite CGM Features
[08:30] How Diabetes Impacts Health Behaviors
[09:25] What It Means to be a Dexcom Warrior
[11:14] Goals for Health & Life
[15:50] Q&A

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}
^{*Fingersticks requred for diabetes treatment decisions if symptoms or expectations do not match readings.}

^MAT-10392

Expert Presentations

Expert Presentations - Type 2 Diabetes

Yes

Related Resources

ADA 2025 - Innovations in Dexcom Technology

ADA 2025 - Team Care, Education and Early CGM Use in Type 2 Diabetes

Premium Content

ADA 2025 - Innovations in Dexcom Technology

alexa.stelzer — Mon, 11 Aug 2025 14:09:41 +0000

ADA 2025 - Innovations in Dexcom Technology

08/21/2025

alexa.stelzer Mon, 08/11/2025 - 14:09

Presented June 21, 2025

Innovations in Dexcom Technology

Event: American Diabetes Association (ADA) 85th Scientific Sessions

Location: Chicago, IL

Date: June 21, 2025

Speaker: Anita Swamy, MD; Assistant Professor, Northwestern University Feinberg School of Medicine; Department of Pediatrics, Division of Pediatric Endocrinology; Associate Clinician, Ann and Robert H. Lurie Children's Hospital of Chicago; Medical Director, Chicago Children's Diabetes Center

Session Overview:

In this 12-minute presentation from the ADA 85th Scientific Sessions, Dr. Anita Swamy delivers the second segment of the "Expanding the Dexcom Portfolio" session. She highlights key advancements in Dexcom technology, including the introduction of the Dexcom G7 15-day sensor and Stelo. Dr. Swamy also explores new product features such as photo logging and AI-powered insights, offering a comprehensive overview of the latest innovations. This session is part of a three-part presentation that also included: Team Case, Education, and Early CGM Use in Type 2 Diabetes and Living Your Best Life with Lance Bass.

Video Timestamps:

[00:01] Dexcom Portfolio Overview
[02:18] Intro to Dexcom G7 15 Day
[06:42] New Dexcom G7 Features
[06:49] Photo Logging Feature
[08:55] Clarity Data in Dexcom G7 App & Receiver
[09:41] Direct to Apple Watch
[10:17] Stelo Personalized Glycemic Health Insights
[11:46] Oura Ring Connectivity

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10359

Expert Presentations

Expert Presentations - Type 2 Diabetes

Yes

Related Resources

ADA 2025 - Team Care, Education and Early CGM Use in Type 2 Diabetes

ADA 2025 - Living Your Best Life with Lance Bass

Premium Content

Off

ADA 2025 - Team Care, Education and Early CGM Use in Type 2 Diabetes

alexa.stelzer — Wed, 16 Jul 2025 20:59:09 +0000

ADA 2025 - Team Care, Education and Early CGM Use in Type 2 Diabetes

08/12/2025

alexa.stelzer Wed, 07/16/2025 - 20:59

Presented June 21, 2025

Team Care, Education and Early CGM Use in Type 2 Diabetes

Event: American Diabetes Association (ADA) 85th Scientific Sessions

Location: Chicago, IL

Date: June 21, 2025

Speaker: Dr. Richard M. Bergenstal, Endocrinologist and Executive Director, International Diabetes Center, HealthPartners Institute

Session Overview:

In this 13-minute video from the ADA 85th Scientific Sessions, Dr. Bergenstal presents the first of three segments in the "Expanding the Dexcom Portfolio" session, exploring how continuous glucose monitoring (CGM) is reshaping diabetes care. Dr. Bergenstal outlines a stepwise path to innovation—from advanced sensor technology to clinical validation to real-world implementation.

Key Takeaways for Healthcare Providers:

CGM as a standard of care: The ADA now recommends CGM for all individuals on insulin, recognizing it as a primary tool for assessing glycemic status beyond A1C.
Expanding access: Dr. Bergenstal presents new data showing CGM benefits extend to people not on insulin, including those using GLP-1 therapies.
Clinical integration: Resources from Dexcom and the International Diabetes Center support providers with tools to incorporate CGM into workflows, educate patients, and interpret data efficiently.
Policy momentum: NCQA has begun incorporating CGM metrics into HEDIS measures, signaling broader systemic support.
Call to action: The speaker urged earlier CGM adoption—even in prediabetes—and advocated for CGM and diabetes education to be foundational steps in treatment algorithms.

This session laid the groundwork for two additional presentations, Innovations in Dexcom Technology and Living Your Best Life with Lance Bass. Access the microsite and resources discussed in this presentation at dexcom.com/clinic-workflow.

Video Timestamps:

[00:02] How CGM is Transforming Diabetes Care
[02:04] 2025 Guidelines for Care
[03:55] State of Type 2 Diabetes Report
[05:28] Clinic Workflow: Getting Started with CGM
[06:02] Resources for Patients and Providers
[07:30] CGM & GLP-1 Use
[09:39] CGM Use in Non-Insulin Therapy
[10:03] Implementation Algorithm

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-10190

Expert Presentations

Expert Presentations - Type 2 Diabetes

Yes

Related Resources

ADA 2025 - Innovations in Dexcom Technology

ADA 2025 - Living Your Best Life with Lance Bass

Premium Content

Off

ACP 2025 - Streamlining Diabetes Management with CGM Technology

alexa.stelzer — Wed, 25 Jun 2025 18:56:15 +0000

ACP 2025 - Streamlining Diabetes Management with CGM Technology

07/03/2025

alexa.stelzer Wed, 06/25/2025 - 18:56

Presented April 17, 2025

Streamlining Diabetes Management with Dexcom CGM Technology in Your Practice

Event: American College of Physicians (ACP) Internal Medicine Meeting

Location: San Francisco, CA

Date: April 17, 2025

Speakers: Thomas Grace, MD; Thomas Martens, MD, FACP, Gregg Simonson, PhD

Session Overview:

With over 130 million Americans affected by diabetes and pre-diabetes, effective management tools are crucial. This 40-minute presentation emphasizes integrating CGM technology into clinical workflows. By using real-time and retrospective CGM data, healthcare providers can tailor treatment plans and improve patient outcomes. This approach enhances collaboration between providers and patients.

This conference presentation showcased the transformative potential of CGM technology in diabetes management. By adopting structured workflows and utilizing tools like the ambulatory glucose profile report, healthcare providers can offer more effective care, ultimately improving patients' quality of life.

Access the microsite and resources discussed in this presentation at dexcom.com/clinic-workflow.

Session Recording:

Video Timestamps:

[00:04] Diabetes in the U.S. – Prevalence Overview
[01:12] Dexcom’s Clinical Portfolio Overview
[05:39] Why Providers Need a Clinic Workflow
[09:00] Introduction to Clinic Workflow Microsite
[11:02] Workflow Step 1: Identify System
[14:22] Workflow Step 2: Configure & Connect
[18:49] Workflow Step 3: Collaborate Using the Data
[20:16] AGP Report
[24:24] Provider Resources
[29:04] Workflow Step 4: Reimbursement
[30:15] Resources for Patients & Clinics
[32:23] Case Study

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT-9649

Expert Presentations

Expert Presentations - Type 2 Diabetes

Yes

Thomas Martens, MD, FACP

Dr. Martens is a board-certified internist at Park Nicollet Clinic in Minneapolis, Minnesota. He serves as the Medical Director at the International Diabetes Center at Park Nicollet Clinic and HealthPartners Care Group, and is also a research investigator at HealthPartners Institute. He played a key role in the MOBILE study, which helped secure CGM coverage for individuals with type 2 diabetes on basal insulin only.

Gregg Simonson, PhD

Dr. Simonson is the Director of Strategy, Innovation, and Partnerships at the HealthPartners Institute, International Diabetes Center. He also holds an academic appointment as an Adjunct Assistant Professor at the University of Minnesota Medical School.

Thomas Grace, MD, CDCES

Thomas Grace is a Family Medicine doctor in Findlay, Ohio. Dr. Grace and is rated as a Distinguished doctor by MediFind in the treatment of Type 2 Diabetes (T2D). He is also highly rated in 2 other conditions, according to our data. His top areas of expertise are Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Sepsis, Type 1 Diabetes (T1D), and Pacemaker Implantation.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 1 clinical trial in the past 15 years. In particular, he has co-authored 1 article and participated in 1 clinical trial in the study of Type 2 Diabetes (T2D).

Related Resources

ATTD 2025 - Revolutionizing Type 2 Diabetes Care with the Latest Innovations in Dexcom Technology

Podcast Episode 23: Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes

Premium Content

Off

ATTD 2025 - Dexcom AID Connections and Recent Advancements

alexa.stelzer — Fri, 09 May 2025 13:56:55 +0000

ATTD 2025 - Dexcom AID Connections and Recent Advancements

05/20/2025

alexa.stelzer Fri, 05/09/2025 - 13:56

Presented March 21, 2025

Dexcom AID Connections and Recent Advancements

Event: Advanced Technologies & Treatments for Diabetes (ATTD) 2025 Conference

Location: Amsterdam, The Netherlands

Date: March 21, 2025

Presenter: Davida Krueger, MSN, APN-BC, BC-ADM

Symposium Overview:

Diabetes management for both type 1 and type 2 diabetes continues to encounter significant challenges, including limited time and resources, diverse technical platforms, and patients' struggles to achieve optimal outcomes. Discover how Dexcom is driving innovation to create a more connected and effective ecosystem for diabetes care by leveraging cutting-edge technology to enhance patient engagement, improve outcomes, and streamline diabetes management. This presentation highlights the advancements in automated insulin delivery (AID) systems and electronic medical record (EHR) integration.

Session Timestamps:

[00:29] EHR Direct Integration
[01:35] Recent AID Publications
[01:54] Control-IQ Observational (CLIO) Study
[03:43] SECURE-T2D Pivotal Trial
[09:13] Control-IQ+ in Type 2 Diabetes
[09:44] Reduction in Diabetes Distress

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}
^{BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at}^{https://www.dexcom.com/safety-information}^{and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.}

^{BRIEF SAFETY STATEMENT: The web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional.}

^{Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2024 Dexcom, Inc. All rights reserved.}

^MAT#-8906

Expert Presentations

Expert Presentations - Type 2 Diabetes

Expert Presentations - Type 1 Diabetes

Expert Presentations - Automated Insulin Delivery

Clinical Evidence - Automated Insulin Delivery

Yes

Related Resources

ATTD 2025 - Dexcom CGM: All Ages All Stages of Diabetes

Podcast Episode 24: Type 2 Diabetes Management Through Glucose Tracking

Premium Content

ATTD 2025 - Dexcom CGM: All Ages All Stages of Diabetes

alexa.stelzer — Fri, 11 Apr 2025 18:39:51 +0000

ATTD 2025 - Dexcom CGM: All Ages All Stages of Diabetes

04/28/2025

alexa.stelzer Fri, 04/11/2025 - 18:39

Presented March 20, 2025

Dexcom CGM: All Ages All Stages of Diabetes

Event: Advanced Technologies & Treatments for Diabetes (ATTD) 2025 Conference

Location: Amsterdam, The Netherlands

Date: March 20, 2025

Symposium Overview:

Dexcom sponsored three educational programs at ATTD 2025, including this unopposed educational program. Professor Tadej Battelino is the session moderator and one of the speakers, addressing the EU perspective on using real-time CGM for all ages and stages of diabetes management. Drs. Satish Garg and Lori Laffel will reveal the most recent advances in Dexcom's G-series technology for adults and pediatrics, and share their research finding and clinical insights. Dexcom's Chief Operating Officer, Jake Leach, will discuss Dexcom's focus and commitment as the technology leader, and the recent advancements in quality and innovation. Finally, Dr. Richard Bergenstal will share his clinical expertise in using CGM as the primary tool for medical optimization and behavior change. The symposium concludes with a panel discussion.

Panel Timestamps:

[00:27] CGM: All Ages, All Stages - An EU Perspective
Speaker: Dr. Tadej Battelino, MD, PhD
[07:42] Dexcom G7 15-Day Performance & Real-Life CGM Use in Diabetes
Speaker: Dr. Satish Garg
[30:11] Dexcom G7 Next Generation Algorithm: Accuracy & Performance in Pediatrics & Pregnancy
Speaker: Dr. Lori Laffel, MD, MPH
[43:27] Building the Future of CGM Innovation Together
Speaker: Jake Leach, Executive Vice President and Chief Operating Officer, Dexcom
[59:32] Medication Optimization Through the Eyes of CGM
Speaker: Dr. Rich Bergenstal, MD
[01:18:36] Panel Discussion

^{The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.}

^MAT#-8535

Expert Presentations

Expert Presentations - Type 2 Diabetes

Yes

Related Resources

2025 Standards of Care in Diabetes Infographic

Podcast Episode 23: Charting a New Path: How Glucose Sensors are Driving Behavior Change in Prediabetes and Type 2 Diabetes

Premium Content

ATTD 2025 - Revolutionizing Type 2 Diabetes Care with the Latest Innovations in Dexcom Technology

alexa.stelzer — Fri, 11 Apr 2025 16:03:14 +0000

ATTD 2025 - Revolutionizing Type 2 Diabetes Care with the Latest Innovations in Dexcom Technology

05/27/2025

alexa.stelzer Fri, 04/11/2025 - 16:03

Presented March 19, 2025

Revolutionizing Type 2 Diabetes Care with the Latest Innovations in Dexcom Technology

Event: Advanced Technologies & Treatments for Diabetes (ATTD) 2025 Conference

Location: Amersterdam, The Netherlands

Date: March 19, 2025

Symposium Overview:

Continuous Glucose Monitoring (CGM) is revolutionizing diabetes management, providing life-changing insights for individuals on insulin. But what about those with type 2 diabetes (T2D) who are not using insulin? Recent updates to the ADA 2025 Standards of Care now recommend CGM for adults with T2D using glucose-lowering agents beyond insulin.¹

This symposium will explore how CGM optimizes glucose levels early, enabling healthcare professionals to make timely therapeutic decisions.²Learn how CGM shifts the focus from simple glucose monitoring to empowering users to connect the dots between food, activity, medication, and glucose patterns.³ These actionable insights help users take control of their health journey.

Join as Dexcom unveils exciting advancements in its CGM portfolio designed to drive better outcomes for all.

Panel Timestamps:

[01:20] Exploring the Clinical Value of CGM Use in Type 2 Diabetes Management
Speaker: Dr. Sufyan Hussain, MA, MRCP, PhD
[06:16] The Role of Technology in Optimizing Basal Insulin in Type 2 Diabetes
Speaker: Dr. Viral Shah, MD
[24:19] Thinking Beyond Basal Insulin in Type 2 Diabetes
Speaker: Dr. Thomas Martens, MD, FACP
[37:47] Dexcom ONE+ in Primary Care for Type 2 Diabetes Insulin Management
Speaker: Dr. Sarah Davies, MBBCh (Hons), FRCP, MRCGP
[53:55] Supporting Health Behavior Change in Type 2 Diabetes
Speaker: Rachel Stahl-Salzman, MS, RD, CDN, CDCES

References:

Diabetes Care 2025; 48(Suppl. 1): S6-S13.
Ajjan RA, et al. Nat Rev Endocrinol. 2024; 20(7):426-440.
Clark TL, et al. Diabetes Technol Ther. 2024;25(10):700-708.

This is a recording of a live presentation. The information you see or hear at this event provides details about medical products which are not available in all countries, may have different indications, and/or have not received approval or market clearance by all governmental regulatory bodies throughout the world. Nothing shown or stated herein should be construed as a solicitation, advertisement, or promotion of any product, or of an indication of any specific use for any product, which is not authorized by the laws and regulations of the country where you reside.

The content may include the presenter’s own experience sharing and data – please do not record or distribute the presentation slides.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.

BRIEF SAFETY STATEMENT: The web-based Dexcom Clarity software is intended for use by both home users and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis, and evaluation of historical CGM data to support effective diabetes management. It is intended for use as an accessory to Dexcom CGM devices with data interface capabilities. Caution: The software does not provide any medical advice and should not be used for that purpose. Home users must consult a healthcare professional before making any medical interpretation and therapy adjustments from the information in the software. Caution: Healthcare professionals should use information in the software in conjunction with other clinical information available to them. Caution: Federal (US) law restricts this device to sale by or on the order of a licensed healthcare professional.

STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.

Dexcom, Dexcom Clarity, Dexcom Follow, Dexcom One, Dexcom Share, Stelo, and any related logos and design marks are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. ©2024 Dexcom, Inc. All rights reserved.

MAT#-8534

Expert Presentations

Expert Presentations - Type 2 Diabetes

Yes

Related Resources

ATTD 2025 - Dexcom CGM: All Ages All Stages of Diabetes

Podcast Episode 24: Type 2 Diabetes Management Through Glucose Tracking

Premium Content